The Effect of Iron and Erythropoietin Treatment on the A1C of Patients With Diabetes and Chronic Kidney Disease

OBJECTIVE: To examine the effect of intravenous iron and erythropoietin-stimulating agents (ESAs) on glycemic control and A1C of patients with diabetes and chronic kidney disease (CKD). RESEARCH DESIGN AND METHODS: This was a prospective study of patients with type 2 diabetes and CKD stage IIIB or I...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Jen M., Cooke, Michelle, Bhandari, Sunil, Atkin, Stephen L., Kilpatrick, Eric S.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963485/
https://www.ncbi.nlm.nih.gov/pubmed/20798337
http://dx.doi.org/10.2337/dc10-0917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963485/
https://www.ncbi.nlm.nih.gov/pubmed/20798337
http://dx.doi.org/10.2337/dc10-0917

Ejemplares similares